| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (methicillin-resistant) |
0.0078 |
0.0078 |
? － ? |
Rifampicin (Rifampin) |
1082 |
| Staphylococcus aureus (methicillin-resistant) |
0.0078 |
0.016 |
? － ? |
Rifalazil (ABI-1648, KRM-1648) |
1082 |
| Staphylococcus aureus (methicillin-resistant) |
0.008 |
0.008 |
0.004 － 0.5 |
Rifampicin (Rifampin) |
410 |
| Staphylococcus aureus (methicillin-resistant) |
0.008 |
0.015 |
0.002 － 0.125 |
API-1252 |
169 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.015 |
≤0.008 － >128 |
Rifampicin (Rifampin) |
178 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.03 |
0.008 － 0.03 |
BC-7013 |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.015 |
0.03 |
0.015 － 0.03 |
PD 124816 |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.03 |
0.015 － 0.03 |
Difluoroquinolone (PD 117596) |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.03 |
0.015 － 0.06 |
AC98-6446 |
175 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.06 |
0.015 － 0.06 |
Clinafloxacin (PD 127391) |
248 |
| Staphylococcus aureus (methicillin-resistant) |
0.03 |
0.06 |
≤0.015 － 0.125 |
Dalbavancin |
72 |
| Staphylococcus aureus (methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 256 |
Rifampicin (Rifampin) |
497 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
0.12 |
0.03 － 0.25 |
Retapamulin |
120 |
| Staphylococcus aureus (Methicillin-resistant) |
0.06 |
0.125 |
0.03 － 0.125 |
Retapamulin |
596 |
| Staphylococcus aureus (Methicillin-resistant) |
0.06 |
0.125 |
0.06 － 0.25 |
Retapamulin |
596 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
0.25 |
0.008 － 0.5 |
ACH-702 |
1279 |
| Staphylococcus aureus (methicillin-resistant) |
0.06 |
16 |
≤0.06 － 64 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
396 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.12 |
0.06 － 0.12 |
Retapamulin |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.03 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
475 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.06 － 1 |
Tigecycline (GAR-936, Tigacyl) |
42 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
604 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
<0.12 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
1060 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.12 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
311 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
214 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.25 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
36 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
0.5 |
0.06 － 1 |
NB2001 |
186 |
| Staphylococcus aureus (methicillin-resistant) |
0.12 |
8 |
0.03 － 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
1060 |
| Staphylococcus aureus (methicillin-resistant) |
>0.12 |
>8 |
≤0.03 － >8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |